129 related articles for article (PubMed ID: 381947)
1. The action of the dihydro derivatives of prostacyclin--(6R)-PGI1 and (6S)-PGI1 on the heart and the coronary vasculature.
Schrör K
Naunyn Schmiedebergs Arch Pharmacol; 1979 Apr; 306(3):213-7. PubMed ID: 381947
[TBL] [Abstract][Full Text] [Related]
2. Effects of prostacyclin on coronary circulation, heart rate and myocardial contractile force in isolated hearts of guinea pig and rabbit - comparison with prostaglandin E2.
Schrör K; Moncada S
Prostaglandins; 1979 Mar; 17(3):367-73. PubMed ID: 382264
[TBL] [Abstract][Full Text] [Related]
3. The effects of prostacyclin (PGI2) on tissues which detect prostaglandins (PG'S).
Omini C; Moncada S; Vane JR
Prostaglandins; 1977 Oct; 14(4):625-32. PubMed ID: 339280
[TBL] [Abstract][Full Text] [Related]
4. Prostacyclin (PGI2) is a weak contractor of coronary arteries of the pig.
Dusting GJ; Moncada S; Vane JR
Eur J Pharmacol; 1977 Oct; 45(3):301-4. PubMed ID: 336382
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular and electrophysiological analysis of a selective vasodilatory prostacyclin analogue, 5-nitro-PGI1.
Kecskeméti V; Stadler I; Körmöczy P
Biomed Biochim Acta; 1984; 43(8-9):S287-90. PubMed ID: 6440542
[TBL] [Abstract][Full Text] [Related]
6. Transformation of arachidonic acid and prostaglandin endoperoxides by the guinea pig heart. Formation of RCS and prostacyclin.
Schrör K; Moncada S; Ubatuba FB; Vane JR
Eur J Pharmacol; 1978 Jan; 47(1):103-14. PubMed ID: 338313
[TBL] [Abstract][Full Text] [Related]
7. Prostacyclin-induced coronary vasodilation. Interactions with adenosine, cyclic AMP and energy charge in the rat heart in vitro.
Schrör K; Link HB; Rösen R; Klaus W; Rösen P
Eur J Pharmacol; 1980 Jun; 64(4):341-8. PubMed ID: 6156077
[TBL] [Abstract][Full Text] [Related]
8. The specificity of prostaglandin E2 (PGE2) in reducing coronary vascular resistance: A comparison with adenosine.
Schrör K; Berg-Becker M; Nookhwun C
Basic Res Cardiol; 1978; 73(3):287-97. PubMed ID: 687323
[TBL] [Abstract][Full Text] [Related]
9. [The importance of increased prostaglandins and prostacyclin for the effect of oxyfedrin in isolated guinea pig heart preparations].
Mentz P; Förster W
Arzneimittelforschung; 1984; 34(12):1739-42. PubMed ID: 6397198
[TBL] [Abstract][Full Text] [Related]
10. Prostacyclin (PGI2) decreases the cyclic AMP level in coronary arteries.
Schrör K; Rösen P
Naunyn Schmiedebergs Arch Pharmacol; 1979 Jan; 306(1):101-3. PubMed ID: 218118
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin E receptor subtypes in smooth muscle: agonist activities of stable prostacyclin analogues.
Dong YJ; Jones RL; Wilson NH
Br J Pharmacol; 1986 Jan; 87(1):97-107. PubMed ID: 2420404
[TBL] [Abstract][Full Text] [Related]
12. The cardiac effects of prostaglandins and their modification by the prostaglandin antagonist N-0164.
Allan G; Levi R
J Pharmacol Exp Ther; 1980 Jul; 214(1):45-9. PubMed ID: 6993659
[TBL] [Abstract][Full Text] [Related]
13. Prostacyclin (PGI2) induces coronary vasodilatation in anaesthetised dogs.
Dusting GJ; Chapple DJ; Hughes R; Moncada S; Vane JR
Cardiovasc Res; 1978 Dec; 12(12):720-30. PubMed ID: 376143
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological evaluation of 5-(Z,E)-13,14-didehydro-20-methyl-carboprostacyclin (FCE 22509).
Ceserani R; Grossoni M; Ukmar G; Colombo M; Mongelli N
Prostaglandins Leukot Med; 1986 Mar; 21(3):231-45. PubMed ID: 3517883
[TBL] [Abstract][Full Text] [Related]
15. Coronary vasodilator activity of 13,14-dehydroprostacyclin methyl ester: comparison with prostacyclin and other prostanoids.
Hyman AL; Kadowitz PJ; Lands WE; Crawford CG; Fried J; Barton J
Proc Natl Acad Sci U S A; 1978 Jul; 75(7):3522-6. PubMed ID: 356056
[TBL] [Abstract][Full Text] [Related]
16. Interactions of isoprenaline and prostaglandin E2 with respect to myocardial contractile force, coronary vascular resistance and myocardial oxygen consumption in guinea-pig isolated hearts.
Krebs R; Schrör K
Br J Pharmacol; 1976 Aug; 57(4):533-41. PubMed ID: 963342
[TBL] [Abstract][Full Text] [Related]
17. Increase in the coronary vascular resistance by indomethacin in the isolated guinea pig heart preparation in the absence of changes in mechanical performance and oxygen consumption.
Schrör K; Krebs R; Nookhwun C
Eur J Pharmacol; 1976 Sep; 39(1):161-9. PubMed ID: 964300
[TBL] [Abstract][Full Text] [Related]
18. The relative activity of prostacyclin (PGI2) and a stable analogue 6beta-PGI1 on the gastrointestinal and cardiovascular systems.
Whittle BJ; Boughton-Smith NK; Moncada S; Vane JR
J Pharm Pharmacol; 1978 Sep; 30(9):597-9. PubMed ID: 29109
[No Abstract] [Full Text] [Related]
19. Vascular relaxing activity and stability studies of 10,10-difluoro-13,14-dehydroprostacyclin.
Hatano Y; Kohli JD; Goldberg LI; Fried J; Mehrotra MM
Proc Natl Acad Sci U S A; 1980 Nov; 77(11):6846-50. PubMed ID: 7005902
[TBL] [Abstract][Full Text] [Related]
20. Relaxation by prostacyclin (PGI2) and 7-oxo-PGI2 of isolated cerebral, coronary and mesenteric arteries.
Malomvölgyi B; Hadházy P; Magyar K; Kánai K; Simonidesz V
Acta Physiol Acad Sci Hung; 1982; 60(4):251-6. PubMed ID: 6764858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
